Oscar Health (OSCR) Stock Forecast & Price Target
$8.02B
Market Cap
17.82
P/E
16.00
Forward P/E
62
Score
OSCR price $30.93 +0.45 +1.48%
Stocklytics score rationale: value 70, quality 58, growth 58.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 553779000 | 589641000 | 1920961000 | 4125584000 | 5862869000 | 9177564000 | 11701427000 |
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar…
Consensus Hold from 11 analysts. Average price target $37.43, +21.0% versus the current price. Low $20.00. High $49.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $37.43 for Oscar Health (OSCR), 21.0% above the current price of $30.93. Of 11 analysts covering the stock, 3 rate it Buy or Strong Buy, 7 Hold, and 1 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $20.00 |
|---|---|
| Average | $37.43 |
| High | $49.00 |
The average is 21.0% above the current price of $30.93.
Of 11 analysts, 3 rate Oscar Health Buy or Strong Buy, 7 Hold, and 1 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
Analyst averages on file: 2026, EPS $1.93, revenue $18.64 billion. 2027, EPS $2.39, revenue $20.87 billion.
The Stocklytics Score for OSCR is 62 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$37.43 average, with a published range of $20.00 to $49.00.
The consensus is Hold from 11 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $1.93. The average revenue estimate is $18.64 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Oscar Health · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$8.02B
Market Cap
17.82
P/E
16.00
Forward P/E
62
Score